8161 — MediNet Income Statement
0.000.00%
- HK$13.73m
- HK$16.50m
- HK$116.25m
- 44
- 53
- 54
- 50
Annual income statement for MediNet, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 145 | 129 | 121 | 110 | 116 |
Cost of Revenue | |||||
Gross Profit | 71.5 | 70.6 | 65.4 | 56.7 | 56.6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 159 | 125 | 128 | 136 | 124 |
Operating Profit | -14.1 | 4.75 | -6.74 | -25.5 | -7.34 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -14.1 | 4.75 | -6.74 | -25.5 | -8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -14.9 | 4.75 | -6.38 | -25.1 | -8.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -14.9 | 4.75 | -6.22 | -24.9 | -8.08 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14.9 | 4.75 | -6.22 | -24.9 | -8.08 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.285 | 0.035 | -0.164 | -0.358 | -0.151 |